The DNA sequence of the central regulatory locus vir ofBordetela pertussis predicts that three gene products, BvgA, BvgB, and BvgC, are 
The bacterium Bordetella pertussis, which is the causative agent of the human disease whooping cough, coordinately regulates the synthesis of multiple virulence-associated determinants in response to environmental stimuli. This phenomenon, originally defined serologically and termed antigenic modulation by Lacey (19) , is now known to involve the repression of the synthesis of specific factors such as filamentous hemagglutinin, pili, a 69-kDa outer membrane protein, pertussis toxin, adenylate cyclase-hemolysin toxin, and dermonecrotic toxin (2, 9, 10, 16, 20, 23, 44) in the presence of certain compounds, termed modulators. Modulators used frequently in the laboratory are MgSO4 and nicotinic acid; however, the nature of the signals to which B. pertussis may respond in the natural environments of the human host remains a mystery. At the genetic level, a locus termed vir was found to control the synthesis of the aforementioned factors, in that a single insertion of the transposable element TnS or another vir mutation abolished the synthesis of all of these (8, 42, 44) . Spontaneous mutations can also occur within the vir locus and are the source of a phenomenon known historically as phase variation, a term which refers to the occurrence of variants in a population that no longer express the regulated genes, even under nonmodulating conditions, and that are stable upon passage. Two mutational mechanisms that give rise to phase variants have been characterized. One is a frameshift mutation within a string of C residues and can subsequently be observed to revert to vir+ (35) . The other, demonstrated in Bordetella bronchiseptica, is the occurrence of small deletions internal to the vir locus that presumably are nonreverting (26) . The significance of either of these mutations to the biology and natural history of B. pertussis and other Bordetella species is not clear. In addition to the genes whose expression is stimulated by the vir locus, Knapp and Mekalanos identified another class of genes in which expression is regulated in a manner that is opposite to that of the genes mentioned above (18) . These have been termed vir repressed genes (vrg genes).
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All of these studies have clearly demonstrated that the vir locus plays an essential role in this impressive system of regulation. However, support for the notion that vir is directly involved in the sensing of the environment comes from two observations. One is that the vir locus, cloned in E. coli, regulates expression from the cloned filamentous hemagglutinin gene in response to the same modulatory signals that function in B. pertussis (28, 37) . The other comes from an analysis of the DNA sequence of the vir locus (1, 35) . These studies indicate that vir belongs to a family of environmentally responsive bacterial regulatory systems, termed two-component systems (27) . As with other members of this family, the DNA sequence predicts the existence of a protein that spans the inner membrane of the bacterium. This putative protein, BvgC (1), corresponding to the sensor or transmitter component of two-component systems, would sense environmental signals through its N-terminal periplasmic domain and communicate such signals via C-terminal cytoplasmic domains to a second cytoplasmic component, BvgA (1) . BvgA corresponds to the regulator or receiver component of two-component systems and would receive signals from BvgC, which would influence its ability to stimulate or repress transcription of vir-regulated genes. For several other two-component systems, the signaling between the sensor and the regulator has been shown to involve transfer of a phosphate moiety (7) . Interestingly, there is an additional regulator domain near the C-terminal end of BvgC, a configuration that is somewhat unusual for twocomponent systems. Another vir-encoded protein, BvgB, was predicted to be periplasmic and to interact with the N-terminal domain of BvgC in the sensing of external conditions. BvgB was found to share sequence similarity with the N-terminal domain of BvgC (1) .
In this study we set out to test the predictions of the DNA sequence on the localization of the vir-encoded polypeptides BvgA, BvgB, and BvgC. To this end we constructed fusions of the bvg genes to the phoA gene of Escherichia coli. The utility of such fusions in examining the cellular location of proteins and the membrane topology of intrinsic inner membrane proteins has been well documented (22 tion (PCR) (30) . The sequences of the primers are presented in Table 2 . One primer in each reaction consisted of 20 nucleotides corresponding to the start of the open reading frame bvgA or bvgS with the addition of an EcoRI site plus three extra bases at the 5' end to allow efficient cleavage of the amplified product. The second primer in each reaction consisted of 25 or 26 nucleotides corresponding to the sequence of the bvg gene at the desired point of fusion to phoA, with the addition of an XhoI site plus two or three extra bases at the 5' end. After amplification, the reaction mixture was extracted with Tris-HCl-equilibrated phenol and passed through a spin column of Bio-Gel P-10 (Bio-Rad) to remove phenol. The amplified fragment was cleaved with EcoRI and XhoI and electrophoresed on a low-melting-point agarose (Seaplaque; FMC) gel in Tris-acetate-EDTA buffer. The resulting band was excised and ligated to EcoRI-and XhoI-cleaved pSS1295, a tac promotor expression vector. In a subsequent step a SalI-HindIll fragment of pSS1324 that contains the phoA gene was added to this plasmid to create the bvg: :phoA fusion (see Fig. 3 ). Note that for S3 the fusion point primer is in the wrong frame. Fusion S3 was selected as a rare blue colony in this cloning, and subsequent sequence analysis revealed the deletion of 1 bp within the primer (Table 2) . For fusions S4, S5, S7, S8, and S9, sequences between the start of bvgS and the fusion point were supplied by conventional cloning techniques. Fusion S6 was derived from S7 by ligation of bvgS at the BglII site to the Sall-HindIII phoA fragment with the addition of a BglII-XhoI linker. Fusions of bvg genes to the lacZ gene of E. coli were created in an analogous manner, except that an XhoI-HindIII fragment from pSS1462, which contained the lacZ gene, was added in the second step rather than a phoA-containing fragment.
For transfer into B. pertussis, the fusion plasmids were digested with HindIII and ligated to the broad-host-range vector pRK310, which had been digested with HindIII and treated with calf intestinal phosphatase (Pharmacia). After transformation of E. coli DH5ot, tetracycline-resistant colonies were selected. After small-scale plasmid DNA preparations were screened by restriction analysis (4) , the desired plasmids were transformed into E. coli SM10, which provides transfer functions for the pRK310 plasmid. Conjugation to BP536 was as described previously (36), with selection on Bordet-Gengou agar containing tetracycline and streptomycin.
The phosphatase phenotype of E. coli strains was assessed on L agar containing IPTG and XP. That of B. pertussis exconjugants was assessed by transfer of colonies to nitrocellulose filters and incubation with solutions containing XP, as previously described (18) .
Construction of B. pertussis vir deletion strains. BP824, containing a complete deletion of the vir locus, was created by recombination with pSS1212, a derivative of pSS808 that has the 2.5-, 2.7-, and 0.3-kb Eco RI fragments, which encompass the vir locus, replaced with a kanamycin resistance cassette derived from pKanll. This deletion, A824, was crossed into BP536 essentially as described previously (36) . BP907 , containing an in-frame deletion in the bvgA gene, was created as follows. The 2.5-kb EcoRI fragment containing bvgA was subcloned into pBR322. The 12-bp linkers 5'-CGCGTCTCGAGA-3' and 5'-GCTCGAGCTGCA-3' were introduced at the MluI and PstI sites, respectively, within bvgA. An in-frame deletion between these two insertions was created by virtue of the XhoI site present in each linker. The resulting 2.2-kb EcoRI fragment containing the A907 deletion was cloned into pSS1129 to create pSS1435. This plasmid was transformed into SM10 and then transferred to BP536 by conjugation and selection for gentamicin resistance. Exconjugants from this mating were streaked on Bordet-Gengou agar containing streptomycin. Nonhemolytic colonies arising upon streptomycin selection represented the desired recombinants. One of these was picked as BP907.
Purification of fusion proteins. Fusion protein A3, when expressed in E. coli DH5a upon IPTG induction, resulted in the formation of inclusion bodies that were visible by phasecontrast microscopy. Induced cells were collected by centrifugation, resuspended in phosphate-buffered saline (PBS)-1.0 mM phenylmethylsulfonyl fluoride (PMSF), and disrupted by passage through a French pressure cell. The inclusion bodies were collected by centrifugation at 3,000 rpm for 5 min in a Sorval SS34 rotor. The inclusion bodies were solubilized in 6 M guanidine HCI and dialyzed against PBS-1.0 mM PMSF. The fine precipitate that formed was collected and mixed with Freund's adjuvant for immunization.
Fusion protein S3 was released from induced cells as described by Barbieri et al. (3) . The periplasmic extract was dialyzed against PBS-1.0 mM PMSF and then mixed with a slurry of agarose beads linked to a monoclonal antibody to E. coli alkaline phosphatase (Caltag Laboratories) with gentle shaking overnight. The slurry was poured into a column and washed extensively with PBS-1.0 mM PMSF, and the fusion protein was eluted with 3.5 M MgCl2. Fractions containing alkaline phosphatase activity as assayed by the method of Garen and Levinthal (14) were dialyzed against PBS-1.0 mM PMSF and used for immunization.
Antibody preparation. Female retired breeder BALB/c mice were immunized subcutaneously with 50 ,ug of A3 or S3 fusion protein in Freund's complete adjuvant in a total volume of 0.2 ml. Mice were boosted three times, at intervals of 2 weeks, with 50 ,ug of fusion protein alone by intraperitoneal injection. One week after the third boost, the mice were bled from the tail vein, and the serum obtained was used in Western immunoblots. Rabbit anti-alkaline phosphatase was a generous gift of David Low (University of Utah) via Patrick Bavoil (University of Rochester).
Western blots. B. pertussis or E. coli cells were collected from Bordet-Gengou agar or L broth into PBS-1.0 mM PMSF, solubilized by the addition of an equal volume of 2 x sodium dodecyl sulfate (SDS) sample buffer containing 100 mM dithiothreitol, and then heated in a boiling water bath. Samples were electrophoresed on 4 to 20% or 10 to 20% gradient polyacrylamide gels (Integrated Separation Systems). The number of cells per lane was normalized by determining the A550 of the cell suspension. The proteins were transferred electrophoretically to nitrocellulose membranes by using a transfer buffer containing 14.4 g of glycine, 3.025 g of Tris base, and 200 ml of methanol per liter. Membranes were blocked overnight in PBS-0.5% bovine serum albumin and washed four times (3 min per wash) in PTA (PBS, 0.05% Tween 20, 0.02% sodium azide). Mouse antiserum was diluted 1:2,000 (anti-A3) or 1:5,000 (anti-S3) in PTA for incubation with the blot for 2 h. The membranes were washed four times (3 min per wash) in PTA, and the antibody conjugate was added in PTA at the manufacturer's suggested dilution. The goat anti-mouse immunoglobulinalkaline phosphatase conjugate was obtained from Southern Biotechnology Associates, and the goat anti-rabbit immunoglobulin-alkaline phosphatase conjugate was obtained from Promega Corp. After incubation for 1 h, the blots were washed four times (3 min per wash) in PTA and developed by using the ProtoBlot detection system from Promega Corp.
Computer analysis of DNA sequence. Open reading frame analysis and calculation of predicted molecular weights were performed by using the MacVector program (International Biotechnologies, Inc.).
DNA sequencing. Sequencing was performed by the dideoxy-chain termination method with single-stranded templates derived from mpl8 and mpl9 clones (45) removed by centrifugation at 8,000 rpm for 10 min and then 15,000 rpm for 15 min in an SS34 rotor (Sorvall). The supernatant was centrifuged for 1 h at 40,000 rpm in a 50 Ti (Beckman) rotor. The supernatant was collected as the soluble fraction. The pellet, which represented the total membrane fraction, was resuspended in PBS-1.0 mM PMSF. The detergent Lubrol-PX (Pierce) was added to 0.5%, and the sample was spun again at 40,000 rpm for 1 h in a 50 Ti rotor. The supernatant was taken to represent the inner membrane fraction, and the pellet represented the outer membrane fraction. The protein content of the three fractions was determined by using the BCA assay (Pierce), and equal amounts of protein were loaded onto polyacrylamide gels for Western analysis and for staining with Coomassie brilliant blue R.
RESULTS
Revision of the DNA sequence of the vir locus. Several lines of evidence suggested to us that an error was present in the previously determined DNA sequence of the vir locus (1); this error had led incorrectly to the prediction that BvgB and BvgC were separate proteins. These lines of evidence were as follows. (i) All PhoA fusion proteins constructed that had the predicted start of BvgC conferred a Pho-phenotype, including fusions to the predicted periplasmic domain. (ii) PCR-generated fragments between the predicted start and end of bvgB appeared to be out of frame. (iii) Antibodies raised against a BvgB::PhoA fusion protein recognized a much larger protein than expected in Western blots of B. pertussis proteins.
We mapped the error within a 300-bp region containing the error and showed by sequence analysis that a C residue was missing between positions 1582 and 1583 (with reference to the sequence; GenBank accession number M25401) as depicted in Fig. 1 . Thus the sequence around this position should read CAACACCCGCCTG rather than CAACACCG CCTG. As a result, bvgB and bvgC are seen to be part of one larger open reading frame, coding for a single protein. We propose that this protein be called BvgS (for sensor) and that the gene which encodes it be called bvgS.
Phenotype of Bvg::PhoA fusions. To assess the cellular location and membrane topology of the proteins encoded by the vir locus, we constructed plasmids that expressed fusion proteins. The N-terminal sequences of these proteins were those of BvgA or BvgS, and the C-terminal sequence was that of E. coli alkaline phosphatase. Such fusions should confer a Pho+ phenotype only if the N-terminal sequences contain information capable of directing the alkaline phosphatase moiety to the extracytoplasmic compartment (22) . We created these fusions, based on the DNA sequence of the vir locus (1), in a tac promotor expression vector such that only one bvg gene was included and was expressed starting at its predicted translational start site. Due to the inclusion of an EcoRI site in the PCR primers used to create bvg gene fragments, the N terminus of the expressed protein contained an additional Asn-Ser after the initial Met (Fig. 2) . The scheme for construction of these plasmids is depicted in Fig. 3 . Figure 1 shows a map of the vir locus, depicting the points of fusion to the phoA gene. Also shown are the phenotypes conferred by these proteins when expressed in E. coli grown on L agar containing XP, a colorigenic substrate for alkaline phosphatase. To confirm that fusion proteins of the expected size were being produced in these strains, Western blots were performed with anti-PhoA serum (Fig. 4) . Only fusion S1 is anomalous, producing a smaller- with these predictions. All fusions at points before the transmembrane region confer a Pho+ phenotype, whereas all fusions after that point confer a Pho-phenotype.
To provide additional genetic data on the localization of the vir-encoded proteins, the fusions A3 and S3 were converted to lacZ fusions. As expected, these fusions gave results that were the opposite of those seen with the phoA fusions in that A3 conferred a ,-galactosidase-positive phenotype, whereas the strain harboring S3 was ,-galactosidase negative and grew poorly on media containing IPTG.
Detection of BvgA in B. pertussis extracts by Western blotting. The A3 fusion protein, which contains the entire predicted BvgA sequence, was expressed at high levels and formed inclusion bodies in IPTG-induced E. coli cells. This protein was solubilized from inclusion bodies and used to immunize mice to obtain antiserum that recognized BvgA in Western blots. Figure 5 shows a Western blot of whole-cell extracts of B. pertussis strains with the anti-BvgA serum. It can be seen that in BP368-3 (Fig. 5, lane 1) , which corresponds to wild-type B. pertussis, only one major band was detected, with a mobility corresponding to about 23 kDa, in good than-expected reactive band, presumably due to degradation of the non-PhoA portion of this protein in the periplasm. All of the BvgS::PhoA fusions were also expressed in B. pertussis, where they conferred the same phenotypes as those conferred in E. coli. Expression of alkaline phosphatase activity by Si through S6 was dependent on the presence of IPTG in the medium, demonstrating that the lac repressor is synthesized and functions normally in B. pertussis, as has been reported by other authors (11) .
BvgA is predicted to be a cytoplasmic protein, based on its apparent lack of a signal peptide and on its homology to the response regulator class of two-component systems, the other members of which have been found to be cytoplasmic. The Pho-phenotype conferred by the three BvgA fusions support this prediction.
The predicted amino acid sequence of BvgS contains a consensus signal sequence at the N terminus (15) and a predicted membrane-spanning segment from residues 542 to 563 (Fig. 2) . The N-terminal amino acids up to 541 are thus predicted to be periplasmic, and the C-terminal sequences from 564 on are predicted to be cytoplasmic. agreement with a molecular weight of 22,937 predicted from the DNA sequence. Lanes 2 and 3 show the results obtained with BP369-3, which is a spontaneously occurring phase variant of BP368-3, and with BP368-3 grown under modulating conditions (50 mM MgSO4). In both cases the amount of BvgA detected was significantly reduced, in keeping with the observations of others that the vir locus is autoregulated (29, 31) . In BP907, which contains an in-frame deletion of bvgA, no BvgA is detected (Fig. 5, lane 4) . The remaining lanes show that other B. pertussis strains and Bordetella parapertussis and B. bronchiseptica strains contain a protein of similar size.
Detection of BvgS in B. pertussis extracts by Western blotting. The fusion protein S3 could be liberated from IPTG-induced E. coli by a procedure that releases predominantly periplasmic proteins (3) . This suggests that the signal 1 2 3 peptide of BvgS is efficiently cleaved in E. coli. The S3 fusion protein was further purified by immunoaffinity chromatography and used to immunize mice.
When anti-BvgS serum was used in Western blots against whole-cell extracts of B. pertussis, a band corresponding to a size of approximately 140 kDa was seen (Fig. 5, lane 1) . To confirm that this protein was encoded within or was regulated by the vir locus, we examined BP824, in which the entire vir locus is deleted. No protein is detected with the anti-BvgS serum in this strain (Fig. 5, lane 4) . To verify that this protein contained BvgC sequences, we examined BP369-3, a spontaneously occurring phase variant of BP368-3 that is Vir-due to a frameshift mutation late in the region of bvgS corresponding to bvgC (35) . This protein is thus expected to be truncated due to a premature encounter with an otherwise out-of-frame stop codon. The amount of truncation predicted is 11,407 Da. The protein detected by anti-BvgB is, in fact, truncated in BP369-3 (Fig. 6, lane 2) . Interestingly, and in contrast to BvgA, the amount of BvgS produced in the vir mutant strain BP369-3 does not appear to be greatly reduced compared with that in BP368-3. This suggests that bvgS is regulated somewhat differently than is bvgA. Similarly, BP368-3 grown under modulating condi- 4 tions also shows little reduction in the amount of BvgS detected (Fig. 6, lane 3) .
Membrane localization of BvgS. To further analyze the cellular location of BvgS, B. pertussis cells were separated into soluble and membrane fractions, and the membrane fraction was separated into inner and outer membrane fractions based on detergent solubility. The majority of the BvgS protein is found in the inner membrane fraction (Fig. 7B) . The absence from the inner membrane fraction of the major 40-kD porin band present in the outer membrane fraction (17) suggests that primarily inner membrane proteins have been solubilized by the conditions used (Fig. 7A ).
DISCUSSION
We have used the powerful tools of gene fusions to phoA and lacZ to examine the cellular location of products encoded by the vir locus (1) . Based on these results and limited DNA sequence analysis, the organization of the vir locus has been slightly revised. Our The amount of BvgA protein detected in B. pertussis lysates is decreased significantly in cells grown under modulating conditions or in cells harboring mutations in the vir locus. This is consistent with the observations of others that the vir locus is autoregulated at the transcriptional level at promotors upstream of bvgA (29, 31) . Interestingly, the BvgS protein does not appear to be regulated to the same degree. Possible explanations for this would include the presence of a non-vir-regulated promotor for bvgS located within the bvgA gene or the presence of a terminator upstream of the bvgS gene that was capable of terminating transcripts from the vir-stimulated promotor(s) (29, 31 ) but not the low-level constitutive promotor P1. Alternatively, posttranscriptional regulation may be involved. Although the mechanistic basis for this difference in regulation between bvgA and bvgS remains to be elucidated, we can speculate on the role it may play in this regulatory system. In such a context it is reasonable that the sensor protein is always present so that changing environmental conditions may be detected. However, the presumed effector of vir regulation, BvgA, need only be produced under conditions in which the expression of the vir-activated genes is appropriate. Thus BvgS may regulate BvgA activity at two levels, one at the level of synthesis and the other by activation of the BvgA protein via phosphorylation.
It was earlier observed that the primary structure of the predicted BvgB protein showed approximately 30% sequence similarity over its entire length to the N-terminal domain of the predicted BvgC product. Since these two proteins are now seen to be part of the same molecule, this domain is inferred to have a tandemly repeated primary structure, which may reflect a dimeric three-dimensional structure for the periplasmic domain of BvgS. Such a structure could have implications for the mechanism by which the sensing of modulating agents occurs.
The predicted primary structure of the BvgC protein also suggested, by its sequence similarities to two-component systems, that a protein containing both a sensor and a regulator domain was encoded (1, 35) . However, it remained a possibility that, even if such a protein was encoded, it was cleaved after synthesis to produce a separate sensor and regulator molecule. Our results presented here present strong confirmatory evidence that in fact these two domains are present in the BvgS molecule. A similar configuration has been found in the sequence of FrzE from Myxococcus xanthus and VirA of Agrobacterium tumefaciens (40) . Although it remains to be determined what role the additional regulator domain of BvgS plays in the stimulation of expression of vir-regulated genes, a variety of genetic evidence
